Skip to main content
. 2012 Jul 2;103(7):1207–1214. doi: 10.1111/j.1349-7006.2012.02312.x

Figure 2.

Figure 2

Kaplan–Meier curves illustrating the overall survival of breast cancer patients who received anthracycline‐based neoadjuvant and/or adjuvant chemotherapy (A), patients with estrogen receptor (ER) positive status (B), p53 negative status (C), p53 positive status (D), Her‐2 negative status (E), and Her‐2 positive status (F).